Haemolytic uraemic syndromes in the British Isles 1985-8: association with verocytotoxin producing Escherichia coli. Part 1: Clinical and epidemiological aspects.
about
Atypical hemolytic uremic syndromeInterventions for haemolytic uraemic syndrome and thrombotic thrombocytopenic purpuraPathogenesis and diagnosis of Shiga toxin-producing Escherichia coli infectionsHeterogeneity of atypical haemolytic uraemic syndromesAn evidence and consensus based guideline for acute diarrhoea managementIntracellular neutralization of shiga toxin 2 by an a subunit-specific human monoclonal antibody.The serodiagnosis of infections caused by Verocytotoxin-producing Escherichia coli.Nationwide study of haemolytic uraemic syndrome: clinical, microbiological, and epidemiological features.Shiga toxin-producing Escherichia coli infections associated with hemolytic uremic syndrome, Italy, 1988-2000.Sequelae of haemolytic uraemic syndrome.Antibody therapy in the management of shiga toxin-induced hemolytic uremic syndrome.Childhood hemolytic uremic syndrome, United Kingdom and Ireland.Thrombotic thrombocytopenic purpura mimicking acute small bowel Crohn's disease.Enterohaemorrhagic Escherichia coli and Shigella dysenteriae type 1-induced haemolytic uraemic syndrome.Long term renal outcome of childhood haemolytic uraemic syndrome.Hemorrhagic colitis in postdiarrheal hemolytic uremic syndrome: retrospective analysis of 54 children.New insights into the haemolytic uraemic syndromes.Haemolytic uraemic syndromes in the British Isles, 1985-8: association with verocytotoxin producing Escherichia coli. Part 2: Microbiological aspects.Biodistribution and elimination kinetics of systemic Stx2 by the Stx2A and Stx2B subunit-specific human monoclonal antibodies in mice.An outbreak of Shiga toxin-producing Escherichia coli O104:H4 hemolytic uremic syndrome in Germany: presentation and short-term outcome in children.Adenovirus vector expressing Stx1/Stx2-neutralizing agent protects piglets infected with Escherichia coli O157:H7 against fatal systemic intoxication.Catastrophic APS in the context of other thrombotic microangiopathies.Cutaneous and renal glomerular vasculopathy as a cause of acute kidney injury in dogs in the UK.The epidemiology, microbiology and clinical impact of Shiga toxin-producing Escherichia coli in England, 2009-2012.Relationship between red blood cell transfusion requirements and severity of renal disease during the acute stage of hemolytic uremic syndrome.Gram-negative organisms in peritoneal dialysis peritonitis: an early indication for surgery in patients with haemolytic uraemic syndrome?The Antibiotic Polymyxin B Impairs the Interactions between Shiga Toxins and Human Neutrophils.Serodiagnosis by passive hemagglutination test and verotoxin enzyme-linked immunosorbent assay of toxin-producing Escherichia coli infections in patients with hemolytic-uremic syndrome.Diarrhea-associated hemolytic uremic syndrome.A prospective study of exposure to verotoxin-producing Escherichia coli among Canadian children with haemolytic uraemic syndrome. The CPKDRC co-investigators.The role of Escherichia coli O 157 infections in the classical (enteropathic) haemolytic uraemic syndrome: results of a Central European, multicentre study.Detection of verocytotoxin from stool and serological testing of patients with diarrhea caused by Escherichia coli O157 : H7.Vero cytotoxin-producing Escherichia coli, particularly serogroup O 157, associated with human infections in the United Kingdom: 1989-91Haemolytic-uraemic syndrome in Western Australia, 1980 to 1994.Seasonality and other epidemiological features of haemolytic uraemic syndrome and E. coli O157 isolates in Scotland.Advances in haemolytic uraemic syndrome.Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: diagnosis and management.In vitro and in vivo protective efficacies of antibodies that neutralize the RNA N-glycosidase activity of Shiga toxin 2.Selective Evolution of Ligands by Exponential Enrichment to Identify RNA Aptamers against Shiga Toxins.Rare disease surveillance: An international perspective.
P2860
Q21202864-A5098F2B-39BF-48C8-8C8A-B3DEAD095E1DQ24241470-868EFADD-6BB1-4224-9A84-377B3269DDCAQ24550740-DF29E0C8-0D1D-42D7-9590-0462A238490FQ24676319-4ECC8A6C-367E-47F5-B689-139C511FDF7CQ28344642-DDAA87B5-28F8-4145-A998-3820E440D844Q30481790-1F1A6D52-F8E3-4D76-96FE-F07BF37C5D1EQ33328949-B0F5D5DD-C598-4B08-A510-CB3E800ED27CQ33338235-D3B4DE06-D4A9-4B89-BE8F-9C35635C59E9Q33346135-4B162A22-47D0-4870-9566-ADBE8C54D30FQ33361289-3D56B4E4-FA4B-42E6-9F58-1BDD73D31101Q33363266-A9D56E74-CDD8-45A6-9FDA-CE8CAC9A5F01Q33365828-8D7EBE27-F174-41C2-BF0B-1DA95F2AD880Q33369006-F5E402B7-7FD8-4F66-A8D3-D03DBB686A11Q33379683-D049B227-8763-4410-9DC1-305268A328A1Q33382692-2D5EEF07-37D2-409E-B21B-FC7FAB0D369CQ33396461-7BDA479E-8AAC-43DB-8B18-D527EFBFDA24Q33397724-9CE0818A-2831-4316-BC12-67A5B39FF0F5Q33397728-A4CEAA7A-72B2-4B05-A06D-90E5A1F7710DQ33401560-9A499825-41A8-4847-9A37-CD544580C5C0Q33401628-72968965-2565-41E9-9903-B3FDD92D0EDAQ33418526-858AB95C-8878-4094-98BE-111DFD46FD0FQ33419886-8679DCA2-648D-4D9B-93E9-7BD05F544CAFQ33421382-E2BD4F75-9909-4A89-8C8D-EBB7214707FDQ33422389-C31B618C-3A94-4214-BCC3-5018B360745CQ33424142-CBF6C369-7D9B-4182-BDDB-F8897EE9BC40Q33427620-833DAD9F-97EC-48FB-9E91-BFC7365EAA47Q33428611-E1DD9FAE-4AB9-4978-8EA4-4B402545CB62Q33491633-2F40278B-2EB8-4EDA-8C37-289158536ECBQ33492981-DEDF6A9E-50E0-4B4F-8406-9770FDD4996FQ33494314-45699091-5EE0-4FF1-9610-D71C2137EE4AQ33494653-33D9F096-3072-433E-944D-EC77FDC66190Q33494833-1FFAD24A-6F6E-449B-BBEB-9F33BC06267AQ33494928-6602E840-FEF5-4934-B41E-8B69BD60D371Q33498158-4C12E382-61B6-4E38-ACB6-4198F2B70B6CQ33501935-5A628628-72FE-4F26-9CA8-072D29D6EA8DQ33502399-163113A5-88FF-488E-8D43-2BAEB749A393Q33504456-49D87CF3-24B9-46F3-B1F8-27B747CD2F9CQ33545441-9E2821F7-DE3F-4865-A31F-7A7D7376B99BQ33563140-5AD39C10-22F2-4B91-B977-9150A0049B5DQ33582733-F49C1EA2-5A90-41D8-9F78-50E85E16647E
P2860
Haemolytic uraemic syndromes in the British Isles 1985-8: association with verocytotoxin producing Escherichia coli. Part 1: Clinical and epidemiological aspects.
description
1990 nî lūn-bûn
@nan
1990 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
Haemolytic uraemic syndromes i ...... l and epidemiological aspects.
@ast
Haemolytic uraemic syndromes i ...... l and epidemiological aspects.
@en
type
label
Haemolytic uraemic syndromes i ...... l and epidemiological aspects.
@ast
Haemolytic uraemic syndromes i ...... l and epidemiological aspects.
@en
prefLabel
Haemolytic uraemic syndromes i ...... l and epidemiological aspects.
@ast
Haemolytic uraemic syndromes i ...... l and epidemiological aspects.
@en
P2093
P2860
P356
P1476
Haemolytic uraemic syndromes i ...... l and epidemiological aspects.
@en
P2093
P2860
P304
P356
10.1136/ADC.65.7.716
P407
P577
1990-07-01T00:00:00Z